BusinessCann
BusinessCann · page 9
- Press releases
SynBiotic SE & Enchilada Group: Joint Venture To Launch First Cannabis Store In Germany
WHAT will the sale of cannabis products for recreational use look like in Germany?
- Press releases
MGC Pharma Patent Application For CimetrA Approved By European IP Office
MGC PHARMACEUTICALS Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development of phytomedicines, is pleased to announce the grant of a Patent for the Company’s Investigational Medical Product, CimetrATM, from the Slovenian Intellectual Property Office (SIPO).
- Press releases
Akanda To Acquire Portugal-Based Holigen, Securing A Cannabis Sector Leadership Position In Europe, The Middle East & Africa (EMEA) With EU GMP Market Access
INTERNATIONAL medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has entered into a definitive agreement to acquire 100% of the issued and outstanding shares of Holigen Limited (“Holigen”) from The Flowr Corporation (“Flowr”) (TSXV: FLWR, OTC: FLWPF).
- Uncategorized
Demecan liefert erstes medizinisches Cannabis aus eigener deutscher Anlage
DEMECAN, der einzige unabhängige deutsche Hersteller von medizinischem Cannabis, hat die ersten Cannabisblüten zur Abholung durch das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) bereitgestellt.
- Press releases
Demecan Delivers First Medical Cannabis From Its Own German Facility
DEMECAN, the only independent German producer of medical cannabis, has made the first cannabis flowers available for collection by the German Federal Institute for Drugs and Medical Devices (BfArM).
- Opinion
US Hemp Industry Has Sights On Europe As It Looks To Overcome Technical Trade Hurdles
By Patrick Atagi NASCENT and emerging are the adjectives most often used when referring to the American hemp industry.
- Press releases
New Poll Shows European Market Is Ready For Legal Recreational Cannabis
CURALEAF International (the “Company”), Europe’s largest vertically integrated cannabis company, welcomes the findings from a new European poll and report on the European recreational cannabis market, the first of its kind by Hanway Associates, an advisory firm specialising in strategy, research and M&A in the cannabis sector.
- Press releases
MGC Pharmaceuticals Enters Partnership With Sciensus Rare For The Distribution Of CannEpil And CogniCann In The EU And UK
· MGC EXECUTES supply and distribution agreement with international pharmaceuticals company Sciensus Rare. · Sciensus Rare is an established international pharmaceutical services company, specialising in the provision of rare disease medicines through a network of decentralised clinical trials, early access programs and licensed distribution programs. · Sciensus Rare appointed the exclusive distributor of MGC Pharma’s CannEpil® and CogniCann®…
- Press releases
Dr. Reddy’s Laboratories And MediCane Health Announce The Launch Of Medical Cannabis Products In Germany
DR REDDY’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.
- Uncategorized
Dr. Reddy’s Laboratories und MediCane Health kündigen die Einführung von medizinischen Cannabisprodukten in Deutschland an
DR REDDY’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, zusammen mit ihren Tochtergesellschaften zusammen als “Dr.
- Press releases
Major CBD Brands Secure Permission For Continued Sales In The UK, Backed By Newell Sciences With Verdant Health
NEWELL Sciences, with Verdant Health, has been included on the public list of the CBD products granted permission by the Food Standards Agency (‘FSA’) to continue being sold in England and Wales.
- Pharmaceutical
Oxford Cannabinoid Technologies Releases Update On Its Two Lead Compounds
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased to present an update on the development of its two lead compounds.
